Validation of Predictive Pharmacoeconomic Model of Introduction of Medicinal Product Ibrutinib Into Chronic Lymphatic Leukemia Therapy Practice in the Territory of the Russian Federation

Pharmacoeconomics: theory and practice
doi 10.30809/phe.3.2015.7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Moscow Pharmaceutical Society

Related search

Toxocariasis: Current State of the Russian Federation Message 1: Risk of Toxocariasis Infection of the Population on the Territory of the Russian Federation

Epidemiology and Vaccine Prevention
2015English

Mechanism of State Regulation of Competitiveness of Tourist Territory Krasnodar Territory, Russian Federation

MATEC Web of Conferences
Materials ScienceEngineeringChemistry
2018English

Arresting the Inflammatory Drive of Chronic Lymphocytic Leukemia With Ibrutinib

Clinical Cancer Research
Cancer ResearchOncology
2016English

Anticoagulant Therapy in Patients With Chronic Lymphocytic Leukemia Receiving Ibrutinib

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Budget Impact Analysis or Pharmacological Therapy of Chronic Myeloid Leukemia (Cml) With Nilotinib as the Second-Line Treatment in Russian Federation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Three Newly Approved Drugs for Chronic Lymphocytic Leukemia: Incorporating Ibrutinib, Idelalisib, and Obinutuzumab Into Clinical Practice

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

The Analysis of the Excise Taxes’ Use Concerning Goods Importation Into the Territory of the Russian Federation in Terms of the EAEU Membership

Izvestiya of Saratov University. New Series. Series Economics. Management. Law
2019English

Pharmacoeconomic Study of the Eliquis (Apixaban) Use Within the Program of Essential Medicines Provision in the Russian Federation

Medical Technologies. Assessment and Choice
2018English

Freedom of Assembly in the Practice of the Constitutional Court of the Russian Federation

RUDN Journal of Law
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy